Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock and American Depositary Receipts
-
Shares outstanding
-
1,226,467,754
-
Total 13F shares
-
40,767,359
-
Share change
-
+1,237,728
-
Total reported value
-
$1,976,156,783
-
Price per share
-
$48.46
-
Number of holders
-
402
-
Value change
-
+$60,069,349
-
Number of buys
-
174
-
Number of sells
-
162
Institutional Holders of Sanofi - Common Stock and American Depositary Receipts (SNY) as of Q4 2025
As of 31 Dec 2025,
Sanofi - Common Stock and American Depositary Receipts (SNY) was held by
402 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
40,767,359 shares.
The largest 10 holders included
Fisher Asset Management, LLC, Mondrian Investment Partners LTD, ENVESTNET ASSET MANAGEMENT INC, Thrivent Financial for Lutherans, DAVENPORT & Co LLC, NICHOLAS COMPANY, INC., UBS Group AG, Connor, Clark & Lunn Investment Management Ltd., Newport Trust Company, LLC, and TODD ASSET MANAGEMENT LLC.
This page lists
409
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.